Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patientsWilma Barcellini, Alberto Zanella, Ilaria Nichele et al.|Blood|2014Cited by 371
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long‐term responseMiriam Marangon, Francesco Zaja, Nicola Vianelli et al.|European Journal Of Haematology|2016Cited by 90